Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$708.97M$708.97Mderivedno prior Q4 2024 on file Net Income-$56.33M-$56.33MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$20,909,000N/M Operating Cash Flowderived$68,186,000−4.0% Free Cash Flowderived$55,053,000+12.9% Margins · derivedOperating margin2.9%
Net margin-7.9%
ended Dec 31, 2025 · filed Feb 20, 2026 · 51 d after period end